Active Living Research Program

The IMPACT study: The Intergenerational effects of Maternal Physical Activity on Child Development
Project Grant
Researchers:

Dr Sarah Valkenborghs

Description:

Dr Sarah Valkenborghs from the HMRI Active Living Research Program has received a grant to fund her study in child neurodevelopment, investigating if physical activity while pregnant is beneficial for child neurodevelopment after birth. 

more

Asthma and Breathing Research Program
Asthma and Breathing Research Program

Does healthy immune development during pregnancy set babies up for healthy respiratory viral responses
Project Grant
Researchers:

Dr Adam Collison

Description:

Dr Adam Collison from the HMRI Asthma and Breathing Research Program received a grant for his study into bronchiolitis, a severe viral infection that is the leading cause of babies under 12 months being admitted to the John Hunter Children’s Hospital.

more
Improving early detection of childhood neurodevelopmental differences using mid-pregnancy biomarkers and infant behaviours
Project Grant
Researchers:

Associate Professor Vanessa Murphy

Description:

Associate Professor Vanessa Murphy received a grant to fund her project focusing on better early detection of childhood neurodevelopmental differences using mid-pregnancy biomarkers and infant behaviours

more

Other

Investigating the role of iron status and supplementation during pregnancy on respiratory disease in children
Project Grant
Researchers:

Dr Henry Gomez

Description:

Dr Henry Gomez won a grant to investigate the role of iron status and supplementation during pregnancy on respiratory disease in children.

more

Precision Medicine Research Program
Precision Medicine Research Program

Taming free radicals to increase response to standard-of-care treatments for children with high-risk leukaemias
Project Grant
Researchers:

Associate Professor Matt Dun

Description:

Associate Professor Matt Dun from the HMRI Precision Medicine Research Program won for his work in taming free radicals to increase response to standard-of-care treatments for children with high-risk leukaemias that become treatment resistant.

more